clinical trial · NCT07531628
A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants
HealthyVerducatib
brief summary
To assess pharmacokinetics, safety, and tolerability of multiple oral doses of verducatib in healthy Chinese male and female trial participants in order to facilitate the clinical development of verducatib in China.
started
Jun 10, 2026
primary completion
Jul 14, 2026
completion
Aug 26, 2026
last updated
Sep 21, 2026
official title
Pharmacokinetics, Safety, and Tolerability Study of Multiple Oral Doses of Verducatib for 4 Weeks in Healthy Chinese Male and Female Trial Participants (Open-label, Single Arm)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol